Orphazyme A/S Statistics Share Statistics Orphazyme A/S has 0
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 841.5K, so 0% of the outstanding
shares have been sold short.
Short Interest 841.5K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -2.06 and the forward
PE ratio is null.
Orphazyme A/S's PEG ratio is
-0.06.
PE Ratio -2.06 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 2.11 P/FCF Ratio -2.4 PEG Ratio -0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Orphazyme A/S.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.7,
with a Debt / Equity ratio of 0.11.
Current Ratio 4.7 Quick Ratio 4.7 Debt / Equity 0.11 Debt / EBITDA -0.11 Debt / FCF -0.13 Interest Coverage -44
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.52M Employee Count 180 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -1.92M Effective Tax Rate 0.3%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0.8, so Orphazyme A/S's
price volatility has been higher than the market average.
Beta 0.8 52-Week Price Change n/a 50-Day Moving Average 1.51 200-Day Moving Average n/a Relative Strength Index (RSI) 38.22 Average Volume (20 Days) 1,378,810
Income Statement
Revenue n/a Gross Profit n/a Operating Income -621.05M Net Income -633.25M EBITDA -615.85M EBIT -621.05M Earnings Per Share (EPS) -22.32
Full Income Statement Balance Sheet The company has 726.93M in cash and 70.71M in
debt, giving a net cash position of 656.22M.
Cash & Cash Equivalents 726.93M Total Debt 70.71M Net Cash 656.22M Retained Earnings -1.5B Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -539.08M
and capital expenditures -5.1M, giving a free cash flow of -544.18M.
Operating Cash Flow -539.08M Capital Expenditures -5.1M Free Cash Flow -544.18M FCF Per Share -27.21
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
